ATE298567T1 - Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung - Google Patents

Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung

Info

Publication number
ATE298567T1
ATE298567T1 AT01500053T AT01500053T ATE298567T1 AT E298567 T1 ATE298567 T1 AT E298567T1 AT 01500053 T AT01500053 T AT 01500053T AT 01500053 T AT01500053 T AT 01500053T AT E298567 T1 ATE298567 T1 AT E298567T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
ibuprofen
production
composition containing
mixing
Prior art date
Application number
AT01500053T
Other languages
English (en)
Inventor
Perez Maria Teresa Tarre
Faus Xavier Font
Casas Montserrat Trullols
Original Assignee
Aplicaciones Farmacodinamicas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farmacodinamicas filed Critical Aplicaciones Farmacodinamicas
Application granted granted Critical
Publication of ATE298567T1 publication Critical patent/ATE298567T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT01500053T 2000-03-03 2001-03-01 Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung ATE298567T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000522A ES2171110B1 (es) 2000-03-03 2000-03-03 Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.

Publications (1)

Publication Number Publication Date
ATE298567T1 true ATE298567T1 (de) 2005-07-15

Family

ID=8492565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01500053T ATE298567T1 (de) 2000-03-03 2001-03-01 Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung

Country Status (8)

Country Link
EP (1) EP1129709B1 (de)
AT (1) ATE298567T1 (de)
CZ (1) CZ301553B6 (de)
DE (1) DE60111657T2 (de)
DK (1) DK1129709T3 (de)
ES (1) ES2171110B1 (de)
PT (1) PT1129709E (de)
SK (1) SK285338B6 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
EP1942877A4 (de) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc Organoleptisch annehmbare orale dosierformen von ibuprofen, herstellungsverfahren und anwendung
EP1840188B1 (de) 2006-03-31 2011-09-07 Sony Deutschland GmbH Zusammensetzung mit mindestens einer Art von Flüssigkristall
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
EP1974751A1 (de) * 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulierungen für nichtsteroidale entzündungshemmende Arzneimittel
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
DK2253329T3 (en) 2009-04-27 2017-01-16 Laboratorio De Aplicaciones Farm S A Oral ibuprofen lysinate suspension.
TW201038296A (en) * 2009-04-27 2010-11-01 Aplicaciones Farmacodinamicas S A Lab De Ibuprofen lysinate oral suspension
WO2014194872A1 (en) 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers
WO2024246565A2 (en) 2023-06-02 2024-12-05 Ioulia Tseti Pharmaceutical composition comprising ibuprofen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4038314A1 (de) * 1990-11-30 1992-06-04 Puetter Medice Chem Pharm Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
EP1129709A3 (de) 2001-11-14
SK2932001A3 (en) 2001-12-03
DK1129709T3 (da) 2005-10-24
CZ301553B6 (cs) 2010-04-14
DE60111657D1 (de) 2005-08-04
DE60111657T2 (de) 2006-05-04
SK285338B6 (sk) 2006-11-03
ES2171110B1 (es) 2003-06-16
EP1129709A2 (de) 2001-09-05
CZ2001714A3 (cs) 2001-10-17
ES2171110A1 (es) 2002-08-16
EP1129709B1 (de) 2005-06-29
PT1129709E (pt) 2005-10-31

Similar Documents

Publication Publication Date Title
AU2001279631A1 (en) Self-emulsifying active substance formulation and use of this formulation
ES2126536A1 (es) "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion.
PT100234A (pt) Novos esteres de alcoois aminados biciclicos e triciclicos, processo para a sua preparacao
IL157963A0 (en) Hsa-free formulations of interferon-beta
ES2189803T3 (es) Procedimiento.
DK1064935T4 (da) Fast lægemiddelsammensætning med kontrolleret frisætning opnået ved termo-formning
ATE493133T1 (de) Antibiotische/analgetische formulierung und verfahren zur herstellung dieser formulierung
EA200600479A1 (ru) Фармацевтический состав, включающий соединения лантана
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
ATE298567T1 (de) Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
DE69924304D1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
NO303715B1 (no) Stabilt, vandig apparat
HUT60245A (en) Insecticidal compositions comprising 2-aryl-1-(alkoxymethyl)-4-halogen-5-(trifluoromethyl)-pyrrole derivatives as active ingredient and process for producing the active ingredient
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
WO2003028624A3 (en) Levothyroxine compositions and methods
JPS5781409A (en) External plaster
ATE269352T1 (de) 4-benzylaminochinoline konjugate mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung
ATE301452T1 (de) Verfahren zur herstellung einer flüssigen dosierungseinheit und kit
AU2002356685A1 (en) Water-soluble non-effervescent pharmaceutical compositions comprising non-steroidal anti-inflammatory drugs
AU2369801A (en) Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation
DE69108976D1 (de) Neue Polycarbophil enthaltende pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung.
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties